The collectins are collagenous lectins present in serum and lung secretions involved in innate immunity. Pulmonary surfactant proteins A and D (SP-A and SP-D), play important roles in defense against influenza A virus (IAV). Compared to controls, mice lacking SP-D due to gene-deletion (SP-D -/-) have markedly increased lung viral titers and inflammation after IAV infection. IAV infection of these mice will be characterized in more detail for this proposal. A better understanding of the mechanisms through which SP-D inhibits replication of IAV could elucidate why certain people are more susceptible to complications of IAV infection. This proposal will examine in vitro important functional aspects of SP-D relevant to its role in host defense against IAV, including its ability to bind to, aggregate and neutralize infectivity of IAV, and to modulate the interactions of phagocytic cells with IAV. In addition, the antiviral activities of recombinant preparations of polymorphic variants of SP-D will be tested. SP-D -/- have pulmonary lipidosis. Since phospholipid accumulation could play a role in the increased susceptibility SP-D -/- mice to IAV infection, relevant interactions of SP-D or IAV with surfactant phospholipids will also be examined. Another respiratory tract protein called gp340 binds to SP-D, and has cooperative antiviral effects when combined with SP-D. This proposal will examine further the antiviral activity of gp340 and the mechanisms through which it potentiates the antiviral effects of SP-D. Since SP-D binds to IAV, phagocytes, phospholipids and gp340, through its carbohydrate recognition domain (CRD), the contribution of specific parts of the CRD to these functional activities will be intensively examined. A series of recombinant constructs will be made in which parts of the SP-D CRD are replaced with analogous parts of serum collectins. Since several of the serum collectins have stronger ability to neutralize infectivity of IAV than SP-D, and probably differ from SP-D in terms of binding to phagocytes, phospholipids and gp340, this approach should identify more precisely which groups of amino acids on the CRD are critical for these functions. Based on prior experiments, it is likely that the modified forms of SP-D generated for this proposal will have greater ability to inhibit infectivity of IAV than wild type SP-D. This will be tested in vitro and in vivo by intranasal instillation or transgenic expression of some of these novel, recombinant SP-Ds in SP-D -/- mice. This proposal should not only increase our understanding of the complex mechanisms through which SP-D participates in host defense against IAV, but also provide evidence of the feasibility of restoring or enhancing collectin-mediated defense through use of recombinantly modified collectins.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL069031-01
Application #
6421509
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Gail, Dorothy
Project Start
2001-12-12
Project End
2005-11-30
Budget Start
2001-12-12
Budget End
2002-11-30
Support Year
1
Fiscal Year
2002
Total Cost
$318,950
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
White, Mitchell R; Kandel, Ruth; Hsieh, I-Ni et al. (2018) Critical role of C-terminal residues of the Alzheimer's associated ?-amyloid protein in mediating antiviral activity and modulating viral and bacterial interactions with neutrophils. PLoS One 13:e0194001
van Eijk, Martin; Rynkiewicz, Michael J; Khatri, Kshitij et al. (2018) Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus. J Biol Chem 293:10646-10662
De Luna, Xavier; Hartshorn, Kevan L (2017) Influenza Casts a Lung Shadow. Am J Pathol 187:697-699
Nikolaidis, Nikolaos M; Noel, John G; Pitstick, Lori B et al. (2017) Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection. Proc Natl Acad Sci U S A 114:E6613-E6622
Hoeksema, Marloes; van Eijk, Martin; Haagsman, Henk P et al. (2016) Histones as mediators of host defense, inflammation and thrombosis. Future Microbiol 11:441-53
Khatri, Kshitij; Klein, Joshua A; White, Mitchell R et al. (2016) Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions. Mol Cell Proteomics 15:1895-912
Hsieh, I-Ni; Hartshorn, Kevan L (2016) The Role of Antimicrobial Peptides in Influenza Virus Infection and Their Potential as Antiviral and Immunomodulatory Therapy. Pharmaceuticals (Basel) 9:
Tripathi, Shweta; White, Mitchell R; Hartshorn, Kevan L (2015) The amazing innate immune response to influenza A virus infection. Innate Immun 21:73-98
Tripathi, Shweta; Wang, Guangshun; White, Mitchell et al. (2015) Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis. PLoS One 10:e0133454
Hoeksema, Marloes; Tripathi, Shweta; White, Mitchell et al. (2015) Arginine-rich histones have strong antiviral activity for influenza A viruses. Innate Immun 21:736-45

Showing the most recent 10 out of 41 publications